Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Autosomal dominant Alport syndrome due to a COL4A4 mutation with an additional ESPN variant detected by whole-exome analysis.

Izumi Y, Hamaguchi A, Miura R, Nakagawa T, Nakagawa M, Saida K, Miyake N, Nagayoshi Y, Kakizoe Y, Miyoshi T, Kohda Y, Misumi Y, Matsumoto N, Ando Y, Mukoyama M.

CEN Case Rep. 2019 Nov 1. doi: 10.1007/s13730-019-00429-w. [Epub ahead of print]

2.

Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis.

Yamashita T, Ueda M, Nomura T, Okazaki T, Okada M, Tsuda Y, Inoue Y, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Inomata Y, Hibi T, Ando Y.

Neurology. 2019 Oct 15;93(16):714-716. doi: 10.1212/WNL.0000000000008320. Epub 2019 Sep 27. No abstract available.

PMID:
31562191
3.

Characteristics of acquired transthyretin amyloidosis: A case series and review of the literature.

Misumi Y, Ueda M, Masuda T, Tsuda Y, Nomura T, Okada M, Inoue Y, Tasaki M, Obayashi K, Yamashita T, Ando Y.

Neurology. 2019 Oct 22;93(17):e1587-e1596. doi: 10.1212/WNL.0000000000008360. Epub 2019 Sep 11.

PMID:
31511348
4.

Reader response: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.

Ueda M, Yamashita T, Misumi Y, Masuda T, Ando Y.

Neurology. 2019 Jul 30;93(5):228-229. doi: 10.1212/WNL.0000000000007870. No abstract available.

PMID:
31358673
5.

A case of esophageal cancer with human immunodeficiency virus infection that progressed rapidly after neoadjuvant chemoradiotherapy.

Hayakawa Y, Kobayashi K, Sakamoto N, Matsuoka M, Nozaka T, Misumi Y, Matsumoto T, Miura N, Furumoto Y, Asano T, Horiuchi T, Fujiki K.

Clin J Gastroenterol. 2019 Jul 27. doi: 10.1007/s12328-019-01028-z. [Epub ahead of print]

PMID:
31352645
6.

Histopathological and biochemical analyses of prostate corpora amylacea.

Kanenawa K, Ueda M, Isoguchi A, Nomura T, Tsuda Y, Masuda T, Misumi Y, Yamashita T, Ando Y.

Amyloid. 2019;26(sup1):160-161. doi: 10.1080/13506129.2019.1583189. No abstract available.

PMID:
31343347
7.

Changes in nerve excitability indices in hereditary transthyretin amyloidosis.

Yamashita T, Ueda M, Misawa S, Inoue Y, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Kuwabara S, Ando Y.

Amyloid. 2019;26(sup1):9-10. doi: 10.1080/13506129.2019.1582480. No abstract available.

PMID:
31343340
8.

Transthyretin amyloid-related cerebral angiitis after liver transplantation.

Yamashita T, Ohnishi K, Ueda M, Masuda T, Inoue Y, Misumi Y, Ueda A, Obayashi K, Takeya M, Ando Y.

Amyloid. 2019;26(sup1):11-12. doi: 10.1080/13506129.2019.1583179. No abstract available.

PMID:
31343330
9.

Clinical and MRI characteristics and follow-up studies of insulin-derived amyloidosis.

Nagase T, Iwaya K, Zako T, Odaka T, Kogure K, Nemoto Y, Misumi Y, Noritake M, Ando Y, Katsura Y.

Amyloid. 2019;26(sup1):156-157. doi: 10.1080/13506129.2019.1582517. No abstract available.

PMID:
31343315
10.

Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis.

Masuda T, Ueda M, Misumi Y, Nomura T, Inoue Y, Isoguchi A, Kanenawa K, Tasaki M, Yamashita T, Sonoda Y, Obayashi K, Ando Y.

Amyloid. 2019;26(sup1):79-80. doi: 10.1080/13506129.2019.1583198. No abstract available.

PMID:
31343297
11.

A novel transgenic mouse model expressing mutant TTR gene causing oculoleptomeningeal type of ATTRm amyloidosis.

Isoguchi A, Ueda M, Kanenawa K, Masuda T, Misumi Y, Yamashita T, Obayashi K, Ando Y.

Amyloid. 2019;26(sup1):69. doi: 10.1080/13506129.2019.1583190. No abstract available.

PMID:
31343295
12.

Memantine, a Noncompetitive N-Methyl-D-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression.

Inoue Y, Ueda M, Masuda T, Misumi Y, Yamashita T, Ando Y.

Mol Neurobiol. 2019 Dec;56(12):8573-8588. doi: 10.1007/s12035-019-01678-7. Epub 2019 Jul 6.

PMID:
31280448
13.

Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S).

Nakase T, Yamashita T, Matsuo Y, Nomura T, Sasada K, Masuda T, Misumi Y, Takamatsu K, Oda S, Furukawa Y, Obayashi K, Matsui H, Ando Y, Ueda M.

Intern Med. 2019 Sep 15;58(18):2695-2698. doi: 10.2169/internalmedicine.2456-18. Epub 2019 Jun 7.

14.

A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.

Ueda M, Okada M, Mizuguchi M, Kluve-Beckerman B, Kanenawa K, Isoguchi A, Misumi Y, Tasaki M, Ueda A, Kanai A, Sasaki R, Masuda T, Inoue Y, Nomura T, Shinriki S, Shuto T, Kai H, Yamashita T, Matsui H, Benson MD, Ando Y.

J Biol Chem. 2019 Jul 19;294(29):11259-11275. doi: 10.1074/jbc.RA119.007851. Epub 2019 Jun 5.

PMID:
31167790
15.

New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis.

Nomura T, Ueda M, Tasaki M, Misumi Y, Masuda T, Inoue Y, Tsuda Y, Okada M, Okazaki T, Kanenawa K, Isoguchi A, Nakamura M, Obayashi K, Shinriki S, Matsui H, Yamashita T, Ando Y.

Orphanet J Rare Dis. 2019 May 27;14(1):116. doi: 10.1186/s13023-019-1100-y.

16.

A mutant MATR3 mouse model to explain multisystem proteinopathy.

Zhang X, Yamashita S, Hara K, Doki T, Tawara N, Ikeda T, Misumi Y, Zhang Z, Matsuo Y, Nagai M, Kurashige T, Maruyama H, Ando Y.

J Pathol. 2019 Oct;249(2):182-192. doi: 10.1002/path.5289. Epub 2019 Jun 18.

PMID:
31056746
17.

Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.

Agemi Y, Shimokawa T, Sasaki J, Miyazaki K, Misumi Y, Sato A, Aida S, Ishii M, Nakamura Y, Naoki K, Okamoto H.

PLoS One. 2019 Jan 17;14(1):e0210499. doi: 10.1371/journal.pone.0210499. eCollection 2019.

18.

First Transcatheter Aortic Valve Implantation via Carotid Artery Performed in Japan.

Misumi Y, Kuratani T, Maeda K, Toda K, Miyagawa S, Ueno T, Sawa Y.

Ann Thorac Cardiovasc Surg. 2018 Dec 18. doi: 10.5761/atcs.cr.18-00201. [Epub ahead of print]

19.

A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1.

Tasaki M, Ueda M, Hoshii Y, Mizukami M, Matsumoto S, Nakamura M, Yamashita T, Ueda A, Misumi Y, Masuda T, Inoue Y, Torikai T, Nomura T, Tsuda Y, Kanenawa K, Isoguchi A, Okada M, Matsui H, Obayashi K, Ando Y.

J Pathol. 2019 Apr;247(4):444-455. doi: 10.1002/path.5203. Epub 2018 Dec 21.

PMID:
30565683
20.

Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening.

Tsuda Y, Yamanaka K, Toyoshima R, Ueda M, Masuda T, Misumi Y, Ogura T, Ando Y.

Sci Rep. 2018 Dec 14;8(1):17884. doi: 10.1038/s41598-018-36357-5.

21.

Extreme Adhesion Activity of Amyloid Fibrils Induces Subcutaneous Insulin Resistance.

Nakamura M, Misumi Y, Nomura T, Oka W, Isoguchi A, Kanenawa K, Masuda T, Yamashita T, Inoue Y, Ando Y, Ueda M.

Diabetes. 2019 Mar;68(3):609-616. doi: 10.2337/db18-0846. Epub 2018 Dec 14.

22.

YHp as a highly stable, hyper-copy, hyper-expression plasmid constructed using a full 2-μm circle sequence in cir0 strains of Saccharomyces cerevisiae.

Misumi Y, Nishioka S, Fukuda A, Uemura T, Nakamura M, Hoshida H, Akada R.

Yeast. 2019 May;36(5):249-257. doi: 10.1002/yea.3371. Epub 2019 Jan 24.

PMID:
30537227
23.

Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.

Ueda M, Yamashita T, Misumi Y, Masuda T, Ando Y.

Amyloid. 2018 Sep;25(3):143-147. doi: 10.1080/13506129.2018.1531842. Review.

PMID:
30486687
24.

RNA sequencing solved the most common but unrecognized NEB pathogenic variant in Japanese nemaline myopathy.

Hamanaka K, Miyatake S, Koshimizu E, Tsurusaki Y, Mitsuhashi S, Iwama K, Alkanaq AN, Fujita A, Imagawa E, Uchiyama Y, Tawara N, Ando Y, Misumi Y, Okubo M, Nakashima M, Mizuguchi T, Takata A, Miyake N, Saitsu H, Iida A, Nishino I, Matsumoto N.

Genet Med. 2019 Jul;21(7):1629-1638. doi: 10.1038/s41436-018-0360-6. Epub 2018 Nov 23.

PMID:
30467404
25.

Teaching NeuroImages: Morphology of lumbosacral dorsal root ganglia and plexus in hereditary transthyretin amyloidosis.

Masuda T, Ueda M, Kitajima M, Morita K, Misumi Y, Yamashita T, Obayashi K, Yamashita Y, Ando Y.

Neurology. 2018 Nov 6;91(19):e1834-e1835. doi: 10.1212/WNL.0000000000006474. No abstract available.

PMID:
30397049
26.

Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

Aiko N, Shimokawa T, Miyazaki K, Misumi Y, Agemi Y, Ishii M, Nakamura Y, Yamanaka T, Okamoto H.

BMC Cancer. 2018 Oct 22;18(1):1012. doi: 10.1186/s12885-018-4911-7.

27.

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.

Ikeda S, Kato T, Ogura T, Sekine A, Oda T, Masuda N, Igawa S, Katono K, Otani S, Yamada K, Saito H, Kondo T, Hosomi Y, Nakahara Y, Nishikawa M, Utumi K, Misumi Y, Yamanaka T, Sakamaki K, Okamoto H.

BMC Cancer. 2018 Mar 2;18(1):241. doi: 10.1186/s12885-018-4150-y.

28.

Efficacy of an over-the-scope clip for preventing adverse events after duodenal endoscopic submucosal dissection: a prospective interventional study.

Tashima T, Ohata K, Sakai E, Misumi Y, Takita M, Minato Y, Matsuyama Y, Muramoto T, Satodate H, Horiuchi H, Matsuhashi N, Nonaka K, Ryozawa S.

Endoscopy. 2018 May;50(5):487-496. doi: 10.1055/s-0044-102255. Epub 2018 Mar 2.

PMID:
29499578
29.

Self-monitoring of urinary salt excretion as a method of salt-reduction education: a parallel, randomized trial involving two groups.

Yasutake K, Miyoshi E, Misumi Y, Kajiyama T, Fukuda T, Ishii T, Moriguchi R, Murata Y, Ohe K, Enjoji M, Tsuchihashi T.

Public Health Nutr. 2018 Aug;21(12):2164-2173. doi: 10.1017/S1368980018000095. Epub 2018 Feb 20.

PMID:
29458447
30.

Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment.

Ikeda T, Masuda T, Ueda M, Yamashita T, Misumi Y, Shinriki S, Ando Y.

Ann Clin Biochem. 2018 Sep;55(5):571-575. doi: 10.1177/0004563218754587. Epub 2018 Feb 5.

PMID:
29310464
31.

Restrictive Mitral Annuloplasty With or Without Papillary Muscle Approximation for Functional Mitral Regurgitation.

Misumi Y, Masai T, Toda K, Nakamura T, Miyagawa S, Yoshikawa Y, Fukushima S, Saito S, Domae K, Kainuma S, Ueno T, Kuratani T, Daimon T, Sawa Y.

J Heart Valve Dis. 2017 Jul;26(4):447-455.

PMID:
29302944
32.

Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.

Yamashita T, Ueda M, Misumi Y, Masuda T, Nomura T, Tasaki M, Takamatsu K, Sasada K, Obayashi K, Matsui H, Ando Y.

J Neurol. 2018 Jan;265(1):134-140. doi: 10.1007/s00415-017-8640-7. Epub 2017 Nov 24.

PMID:
29177547
33.

A novel transthyretin variant V28S (p.V48S) with a double-nucleotide substitution in the same codon.

Okada M, Misumi Y, Ueda M, Yamashita T, Masuda T, Tasaki M, Ando Y.

Amyloid. 2017 Dec;24(4):231-232. doi: 10.1080/13506129.2017.1381082. Epub 2017 Sep 26. No abstract available.

PMID:
28949257
34.
35.

Staged open repair for a complex adult aortic coarctation.

Misumi Y, Masai T, Kainuma S, Sawa Y.

J Card Surg. 2017 Aug;32(8):500-503. doi: 10.1111/jocs.13179.

PMID:
28833633
36.

Hemiatrophy of the Tongue with Contralateral Hemiparesis in a Patient with Multifocal Acquired Demyelinating Sensory and Motor Neuropathy.

Ikenoshita S, Yamashita S, Sakamoto T, Misumi Y, Ando Y.

J Clin Neurol. 2017 Oct;13(4):422-423. doi: 10.3988/jcn.2017.13.4.422. Epub 2017 Aug 1. No abstract available.

37.

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.

Misumi Y, Okamoto H, Sasaki J, Masuda N, Ishii M, Shimokawa T, Hosomi Y, Okuma Y, Nagamata M, Ogura T, Kato T, Sata M, Otani S, Takakura A, Minato K, Miura Y, Yokoyama T, Takata S, Naoki K, Watanabe K.

BMC Cancer. 2017 May 26;17(1):377. doi: 10.1186/s12885-017-3353-y.

38.

Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.

Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y.

Neurology. 2017 Jun 6;88(23):2192-2197. doi: 10.1212/WNL.0000000000004016. Epub 2017 May 10.

PMID:
28490654
39.

Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin.

Suenaga G, Ikeda T, Masuda T, Motokawa H, Yamashita T, Takamatsu K, Misumi Y, Ueda M, Matsui H, Senju S, Ando Y.

Sci Rep. 2017 May 8;7(1):1579. doi: 10.1038/s41598-017-01775-4.

40.

Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.

Inoue Y, Ueda M, Tasaki M, Takeshima A, Nagatoshi A, Masuda T, Misumi Y, Kosaka T, Nomura T, Mizukami M, Matsumoto S, Yamashita T, Takahashi H, Kakita A, Ando Y.

Acta Neuropathol. 2017 Oct;134(4):605-617. doi: 10.1007/s00401-017-1720-z. Epub 2017 May 6.

PMID:
28478503
41.

A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation.

Matsumoto S, Ueda M, Yamashita T, Amano T, Misumi Y, Tasaki M, Masuda T, Mizukami M, Furuya H, Ando Y.

Amyloid. 2017 Mar;24(sup1):97-98. doi: 10.1080/13506129.2017.1286585. No abstract available.

PMID:
28434367
42.

Identification of amyloid precursor protein from autopsy and biopsy specimens using LMD-LC-MS/MS: the experience at Kumamoto University.

Tasaki M, Ueda M, Obayashi K, Kinoshita Y, Matsumoto S, Mizukami M, Masuda T, Misumi Y, Yamashita T, Ando Y.

Amyloid. 2017 Mar;24(sup1):167-168. doi: 10.1080/13506129.2017.1286583. No abstract available.

PMID:
28434365
43.

In vitro and in vivo assessment of novel derivatives for detecting various amyloid deposits.

Izaki A, Obayashi K, Suenaga G, Ueda M, Yamashita T, Tasaki M, Yanagisawa Y, Masuda T, Misumi Y, Ando Y.

Amyloid. 2017 Mar;24(sup1):17. doi: 10.1080/13506129.2017.1287070. No abstract available.

PMID:
28434362
44.

A case with a novel variant transthyretin A36D presenting cardiac phenotype.

Nomura T, Yamashita T, Misumi Y, Ueda M, Masuda T, Tasaki M, Ando Y.

Amyloid. 2017 Mar;24(sup1):100. doi: 10.1080/13506129.2017.1287072. No abstract available.

PMID:
28434360
45.

Iatrogenic systemic transthyretin amyloid deposits in a case with domino liver transplantation: an autopsy case study.

Tsuda Y, Misumi Y, Ueda M, Tasaki M, Huang G, Masuda T, Suenaga G, Kinoshita Y, Obayashi K, Yamashita T, Ando Y.

Amyloid. 2017 Mar;24(sup1):125. doi: 10.1080/13506129.2017.1287071. No abstract available.

PMID:
28434358
46.

Long-term effects of liver transplantation on small-fiber dysfunction in Japanese transthyretin (ATTR) V30M hereditary amyloidosis with polyneuropathy (FAP).

Obayashi K, Ueda M, Yamashita T, Tasaki M, Izaki A, Yanagisawa Y, Masuda T, Misumi Y, Ando Y.

Amyloid. 2017 Mar;24(sup1):99. doi: 10.1080/13506129.2017.1286586. No abstract available.

PMID:
28434340
47.

Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.

Watanabe T, Obayashi K, Misumi Y, Tasaki M, Shinriki S, Ando T, Akagami T, Ueda M, Yamashita T, Hirotani S, Ando Y.

Amyloid. 2017 Mar;24(sup1):119. doi: 10.1080/13506129.2017.1294057. No abstract available.

PMID:
28434332
48.

Disruption of blood-nerve barriers in hereditary transthyretin (ATTR) amyloidosis.

Koike H, Ikeda S, Takahashi M, Kawagashira Y, Iijima M, Misumi Y, Ando Y, Ikeda SI, Katsuno M, Sobue G.

Amyloid. 2017 Mar;24(sup1):89-90. doi: 10.1080/13506129.2017.1278691. No abstract available.

PMID:
28434331
49.

Clinicopathological and biochemical findings of late-onset hereditary transthyretin amyloidosis 16 years after liver transplantation: an autopsy case study.

Mizukami M, Ueda M, Tasaki M, Misumi Y, Masuda T, Matsumoto S, Yamashita T, Ando Y.

Amyloid. 2017 Mar;24(sup1):122. doi: 10.1080/13506129.2017.1295941. No abstract available.

PMID:
28434327
50.

Occurrence factors and clinical picture of iatrogenic transthyretin amyloidosis after domino liver transplantation.

Misumi Y, Oshima T, Ueda M, Yamashita T, Tasaki M, Masuda T, Obayashi K, Ando Y.

Amyloid. 2017 Mar;24(sup1):123-124. doi: 10.1080/13506129.2017.1278690. No abstract available.

PMID:
28434312

Supplemental Content

Loading ...
Support Center